Trinomab(Zhuhai) Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 48

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $29.1M

  • Investors
  • 23

Trinomab(Zhuhai) General Information

Description

Developer of antibody biopharmaceuticals designed for related medical research services. The company's research revolves around antibodies that can be used to treat viral infections and surgery-caused infections, enabling healthcare providers to prescribe better treatments to their patients.

Contact Information

Website
www.trinomab.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2F, Building 6C, Zhizao Street, Hongqi Town
  • Jinwan District
  • Zhuhai, Guangdong 519000
  • China
+86 0756
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Drug Discovery
Vertical(s)
LOHAS & Wellness, Life Sciences
Corporate Office
  • 2F, Building 6C, Zhizao Street, Hongqi Town
  • Jinwan District
  • Zhuhai, Guangdong 519000
  • China
+86 0756

Trinomab(Zhuhai) Timeline

2022202320242025
Financing Round

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Trinomab(Zhuhai) Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC 17-Apr-2023 $29.1M Completed Clinical Trials - General
4. Later Stage VC 28-Nov-2022 Completed Clinical Trials - General
3. Later Stage VC (Series A1) 08-Sep-2021 Completed Clinical Trials - General
2. Later Stage VC (Series A) 25-Apr-2021 $68.8M $98M Completed Clinical Trials - General
1. Early Stage VC 25-Sep-2018 $29.2M $29.2M Completed Clinical Trials - General
To view Trinomab(Zhuhai)’s complete valuation and funding history, request access »

Trinomab(Zhuhai) Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Trinomab(Zhuhai) Investors (23)

Investor Name Investor Type Holding Investor Since Participating Rounds
China Science and Technology Innovation Venture Capital Minority
Fresscon Capital Venture Capital Minority
Huajin Securities Investment Corporate Venture Capital Minority
Kangjun Capital Venture Capital Minority
Trina Group VC-Backed Company Minority
You’re viewing 5 of 23 investors. Get the full list »

Ready to get started?

Request a free trial

Trinomab(Zhuhai) FAQs

  • When was Trinomab(Zhuhai) founded?

    Trinomab(Zhuhai) was founded in 2015.

  • Where is Trinomab(Zhuhai) headquartered?

    Trinomab(Zhuhai) is headquartered in Zhuhai, China.

  • What is the size of Trinomab(Zhuhai)?

    Trinomab(Zhuhai) has 48 total employees.

  • What industry is Trinomab(Zhuhai) in?

    Trinomab(Zhuhai)’s primary industry is Biotechnology.

  • Is Trinomab(Zhuhai) a private or public company?

    Trinomab(Zhuhai) is a Private company.

  • What is Trinomab(Zhuhai)’s current revenue?

    The current revenue for Trinomab(Zhuhai) is .

  • How much funding has Trinomab(Zhuhai) raised over time?

    Trinomab(Zhuhai) has raised $232M.

  • Who are Trinomab(Zhuhai)’s investors?

    China Science and Technology Innovation, Fresscon Capital, Huajin Securities Investment, Kangjun Capital, and Trina Group are 5 of 23 investors who have invested in Trinomab(Zhuhai).

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »